URAC Medicare Home Infusion Therapy Supplier Accreditation

Last updated: April 2026

What Is URAC Medicare Home Infusion Therapy Supplier Accreditation?

URAC Medicare Home Infusion Therapy Supplier (MHITS) accreditation is a CMS-recognized accreditation program that validates a supplier's compliance with federal Conditions of Coverage for delivering infusion therapy services in patients' homes under the Medicare home infusion therapy benefit. Under the 21st Century Cures Act, home infusion therapy suppliers must hold accreditation from a CMS-approved organization — such as URAC — to receive Medicare reimbursement for infusion nursing visits and training services. IHS provides consulting support to help suppliers build and demonstrate the organizational infrastructure URAC requires.

Why This Accreditation Matters

• Medicare billing eligibility. Without accreditation from a CMS-approved body, a home infusion therapy supplier cannot bill Medicare Part B for professional services under the home infusion benefit. Accreditation is not optional — it is a payment prerequisite.
• CMS deemed status. URAC holds CMS approval through March 27, 2030. Suppliers accredited under URAC's MHITS program satisfy federal Conditions of Coverage without a separate CMS survey.
• Market differentiation. URAC accreditation signals to referral sources, payers, and patients that the organization meets rigorous, independently verified standards for clinical quality, patient safety, and care coordination.
• Operational foundation. The accreditation process produces documented policies, clinical protocols, patient education systems, and quality management structures that strengthen everyday operations — not just the survey response.

Who Needs URAC MHITS Accreditation

Any organization that provides home infusion therapy services to Medicare beneficiaries and seeks reimbursement under the Part B home infusion benefit must be accredited by a CMS-approved accrediting organization. This includes:

• Infusion pharmacies seeking to bill Medicare for home infusion services
• Specialty pharmacies expanding into the home infusion therapy benefit
• Integrated health systems establishing or acquiring home infusion service lines
• Home infusion therapy companies entering new markets or seeking re-accreditation
• Organizations currently accredited by another CMS-approved body considering a transition to URAC

URAC MHITS Standards Structure

URAC's Medicare Home Infusion Therapy Supplier standards address the full operational and clinical lifecycle of a home infusion therapy organization. Key standard domains include:

How IHS Supports MHITS Accreditation

Integral Healthcare Solutions provides consulting from initial readiness through accreditation decision. Our engagement model is built around your organization's actual gap profile — not a generic checklist.

1. Baseline Gap Analysis. We conduct a structured assessment of your current policies, procedures, clinical protocols, and operational practices against URAC's MHITS standards. The output is a prioritized gap register with ownership assignments and remediation timelines.
2. Policy and Procedure Development. We develop or revise the policies, procedures, and clinical protocols required by the standards. Every document is written to survive survey scrutiny — not just to check a box.
3. Staff Education and Competency Preparation. URAC surveyors interview staff at all levels. We prepare your team with standards literacy, interview readiness, and documentation discipline.
4. Application Support. We guide your team through the URAC application process, including narrative responses, supporting documentation assembly, and pre-submission review.
5. Mock Survey. We conduct an internal mock survey simulating the URAC review — standard by standard, document by document — and provide a written corrective action plan before you submit.
6. Survey Support and RFI Response. If URAC issues a Request for Information (RFI) following the survey, IHS drafts your response and coordinates supporting documentation to maximize the likelihood of a clean accreditation decision.

The IHS Advantage: Former URAC Leadership

IHS is led by Thomas G. Goddard, JD, PhD, former Chief Operating Officer and General Counsel of URAC. No other consulting firm offers this depth of insider knowledge of how URAC standards are written, interpreted, and applied in the survey process. When our clients receive an RFI or face a complex standards interpretation question, the answer comes from someone who helped build the program — not someone reading the same manual the client has.